BiotechTubeBiotechTube
Home/Pipeline/MOR-107

MOR-107

Solid Tumors

Phase 1/2Status Uncertain

Key Facts

Indication
Solid Tumors
Phase
Phase 1/2
Status
Status Uncertain
Company
Mochida Pharmaceutical

About Mochida Pharmaceutical

Founded in 1895, Mochida Pharmaceutical is a long-standing Japanese pharmaceutical company focused on the research, development, and commercialization of innovative medicines and healthcare products. The company operates across three core segments: Prescription Pharmaceuticals, Consumer Healthcare (OTC), and Diagnostics. Its strategy combines the lifecycle management of its established revenue-generating products with targeted R&D in areas such as oncology, immunology, and rare diseases to drive future growth.

View full company profile

Therapeutic Areas

DermatologyUrologyOncologyHematologyMetabolic DiseasesImmunology

Other Solid Tumors Drugs

DrugCompanyPhase
GSK4362676GSK plcPhase 1
ABBV-154AbbViePhase 1
TAK-981Takeda PharmaceuticalPhase 1/2
TAK-676Takeda PharmaceuticalPhase 1
TAK-573Takeda PharmaceuticalPhase 1
TAK-164Takeda PharmaceuticalPhase 1
SHR-1316Jiangsu Hengrui MedicinePhase 1/2
BAY 2927088BayerPhase 1
ASP1929Astellas PharmaPhase 2
IBI188Innovent BiologicsPhase 1
Bispecific AntibodyAkesoPhase 1/2
CSPC-DM02CSPC Pharmaceutical Group LimitedPhase 2